The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $55.74

Today's change-0.57 -1.01%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Merck & Co Inc

NYSE: MRK
Last

(U.S.) $55.74

Today's change-0.57 -1.01%
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.

Merck & Co Inc crosses below 20-day moving average

Merck & Co Inc closed lower Thursday, dropping (U.S.)$0.57 or 1.01% to (U.S.)$55.74 and crossing below its 20-day moving average. Shares have lost 1.52% over the last five days, but have gained 5.53% over the last year to date. This security has underperformed the S&P 500 by 5.23% during the last year.

Key company metrics

  • Open(U.S.) $55.89
  • Previous close(U.S.) $56.31
  • High(U.S.) $56.23
  • Low(U.S.) $55.55
  • Bid / Ask(U.S.) $55.26 / (U.S.) $56.42
  • YTD % change+5.53%
  • Volume9,094,747
  • Average volume (10-day)8,082,737
  • Average volume (1-month)8,560,736
  • Average volume (3-month)10,604,198
  • 52-week range(U.S.) $45.69 to (U.S.) $61.70
  • Beta0.68
  • Trailing P/E35.60×
  • P/E 1 year forward15.13×
  • Forward PEG3.09×
  • Indicated annual dividend(U.S.) $1.84
  • Dividend yield3.30%
  • Trailing EPS(U.S.) $1.57
Updated April 28 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.01%Sector:HealthcareIndustry:Pharmaceuticals - Diversified
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue10,21510,0739,7859,425
Total other revenue--------
Total revenue10,21510,0739,7859,425
Gross profit6,4466,3826,1365,961
Total cost of revenue3,7693,6913,6493,464
Total operating expense8,4967,8468,2397,990
Selling / general / administrative2,5602,4292,4712,339
Research & development1,7801,4831,6551,735
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)387243464452
Other operating expenses, total--------
Operating income1,7192,2271,5461,435
Interest income (expense), net non-operating-169-165-174-164
Gain (loss) on sale of assets--------
Other--------
Income before tax8162,3978071,381
Income after tax9821,831688958
Income tax, total-166566119423
Net income9771,826687952
Total adjustments to net income--------
Net income before extra. items9771,826687952
Minority interest-5-5-1-6
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9771,826687952
Inc. avail. to common incl. extra. items9771,826687952
Diluted net income9771,826687952
Dilution adjustment--------
Diluted weighted average shares2,8142,8362,8502,853
Diluted EPS excluding extraordinary itemsvalue per share0.350.640.240.33
Dividends per sharevalue per share0.460.450.450.45
Diluted normalized EPSvalue per share0.440.710.380.44